Dexcom Inc
(DXCM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 289,900 | 146,400 | 541,500 | 285,200 | 164,500 |
| Depreciation Amortization | 104,600 | 52,500 | 186,000 | 133,500 | 85,300 |
| Income taxes - deferred | -56,500 | -41,800 | -55,000 | -136,500 | -51,500 |
| Accounts receivable | 28,000 | -5,800 | -260,100 | -72,900 | -37,100 |
| Other Working Capital | 86,600 | 19,000 | 3,200 | 261,300 | 98,300 |
| Other Operating Activity | 36,000 | 38,900 | 332,900 | 144,300 | 86,200 |
| Operating Cash Flow | $488,600 | $209,200 | $748,500 | $614,900 | $345,700 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -123,000 | -56,900 | -236,600 | -184,100 | -133,700 |
| Purchase Of Investment | -1,776,600 | -992,400 | -3,219,900 | -2,947,900 | -2,149,900 |
| Sale Of Investment | 1,788,600 | 1,121,800 | 2,947,400 | 2,228,400 | 1,557,000 |
| Other Investing Activity | -3,100 | 2,300 | 1,900 | -18,500 | -16,000 |
| Investing Cash Flow | $-114,100 | $74,800 | $-507,200 | $-922,100 | $-742,600 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,230,600 | 1,230,600 | 1,230,600 |
| Debt Repayment | N/A | N/A | -787,300 | -650,500 | N/A |
| Common Stock Issued | 13,400 | 13,400 | 26,600 | 26,600 | 12,300 |
| Common Stock Repurchased | N/A | N/A | -688,700 | -188,700 | -188,700 |
| Other Financing Activity | -10,100 | -8,700 | -99,800 | -104,700 | -103,500 |
| Financing Cash Flow | $3,300 | $4,700 | $-318,600 | $313,300 | $950,700 |
| Exchange Rate Effect | -4,800 | -3,800 | 1,500 | -4,600 | -1,100 |
| Beginning Cash Position | 567,500 | 567,500 | 643,300 | 643,300 | 643,300 |
| End Cash Position | 940,500 | 852,400 | 567,500 | 644,800 | 1,196,000 |
| Net Cash Flow | $373,000 | $284,900 | $-75,800 | $1,500 | $552,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 488,600 | 209,200 | 748,500 | 614,900 | 345,700 |
| Capital Expenditure | -123,000 | -56,900 | -236,600 | -184,100 | -133,700 |
| Free Cash Flow | 365,600 | 152,300 | 511,900 | 430,800 | 212,000 |